SOUTH PLAINFIELD, N.J., Aug. 26, 2010 (GLOBE NEWSWIRE) -- Laxai Pharma, Ltd. (the “Company”) (OTCBB:LAXAF), an international pharmaceutical contract research organization (“CRO”), is pleased to announce that it has published its second quarter results last week for the period ended as of June 30, 2010.
